TECH-MAHINDRA
19.9.2023 16:35:36 CEST | Business Wire | Press release
Tech Mahindra, a leading provider of digital transformation, consulting, and business re-engineering services & solutions, today inaugurated a local innovation centre in Espoo, Finland. This expansion comes after a sustained period of growth in the region and signifies Tech Mahindra’s commitment to further its journey in Finland, and the Nordic region. The new centre will accommodate a diverse workforce – increasing the in-country headcount ranging from experienced business leaders to fresh talent, in collaboration with the local ecosystem.
Located in Espoo, a part of the greater Helsinki metropolitan area, the new centre situates Tech Mahindra at the heart of one of the major business hotspots and innovation hubs in the Nordics. From this strategic location, Tech Mahindra will continue to provide digital business transformation services and solutions to customers.
Mohit Joshi, Managing Director and CEO Designate of Tech Mahindra, said, “Given its focus on innovation, sustainability, and a unique approach to entrepreneurship; today Finland ranks amongst the topmost countries in the world that leverage emerging technologies to shape the future business landscape. This is also reflected in Tech Mahindra’s commitment to the ongoing expansion in the Nordics region, and the establishment of our new centre in Espoo. It is our endeavor to widen the talent pool, fuel innovation, improve agility to deliver robust solutions, and be closer to our customers’ businesses to drive sustainable growth.”
The inauguration ceremony was attended by dignitaries such as Raveesh Kumar, Ambassador of India to Finland; Jusa Susia, Senior Director & Head of Region East Asia & India at Business Finland; and Janne Kari, Head of Industry, ICT and Digitalisation at Invest in Finland. Tech Mahindra representatives include CP Gurnani, Managing Director and CEO; Mohit Joshi, Managing Director and CEO Designate; Mukul Dhyani, Senior Vice President & Business Head Continental Europe; Rajesh Barwal, VP & Country Manager for Sweden and Finland; C-H Hallstrom, Vice President, Strategic Programs, Nordics.
Further to the commitment in 2022 to set up a Makers Lab, Tech Mahindra’s research and development arm in Finland, the newly opened centre will also facilitate innovation in collaboration with new and existing customers in the region. The team will work on new and emerging technologies such as Quantum computing, Generative AI and Metaverse. The Makers Lab will also plug into the local startup ecosystem and universities to provide new opportunities in R&D across industries.
In the ten years since Tech Mahindra entered the Finnish market, the organisation has firmly established itself as a leading business transformation expert in the region. By leveraging deep industry expertise and long-term experience in tailoring and deploying best-in-class solutions, Tech Mahindra continues to help businesses to navigate the complex challenges present in the modern business landscape.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230919543874/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis22.4.2026 07:00:00 CEST | Press release
FDA Fast Track Designation granted to 4P004 for the treatment of knee osteoarthritis, recognizing the disease as a serious condition with significant unmet medical need Designation supports enhanced regulatory interactions and alignment on efficient post-Phase 2a development strategies, including potential accelerated pathways 4Moving Biotech (4MB), a clinical-stage biotechnology company developing next-generation Disease-Modifying Osteoarthritis Drugs (DMOADs), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to 4P004 for the treatment of knee osteoarthritis in patients with synovitis who have not benefited from at least two prior pharmacological therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421591087/en/ 4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis This designation highlight
LTM Wins Two Google Cloud Partner of the Year Awards for 202622.4.2026 04:30:00 CEST | Press release
Recognised for its Media & Entertainment Industry Solutions and Infrastructure Modernization at Scale LTM, the Business Creativity partner to the world’s largest enterprises, announced today that it has received two Google Cloud Partner of the Year 2026 Awards. LTM is being recognized for its achievements in the Google Cloud ecosystem, helping joint customers to drive high-impact, scalable cloud transformations. LTM won the Google Cloud Partner of the Year Award in the Media & Entertainment category by modernizing a global media company's complex data estate with BigQuery. The transformation improved speed, lowered costs, and provided a scalable foundation, enabling real-time analytics and AI-ready pipelines. This approach offers a repeatable model for data modernization in Media and Entertainment industry. Additionally, LTM was honoured with another Google Cloud Partner of the Year Award for Infrastructure Modernization in North America and the transformation of the ERP landscape for
Horse Powertrain Reveals Lightweight Hybrid V6 System at Beijing Auto Show 202622.4.2026 01:01:00 CEST | Press release
Horse Powertrain, a global leader in innovative and low-emission powertrain systems, has revealed the HORSE W30 – the company’s first production-ready V6 engine – ahead of the Beijing Auto Show 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421176701/en/ The front view of the HORSE W30 engine. The HORSE W30 marks a first for Horse Powertrain, in transferring its expertise in developing optimized three- and four-cylinder engines into the V6 category. By deploying its expertise in this way, Horse Powertrain has developed the lightest V6 on the market and created a hybrid-first V6 with outstanding fuel economy and efficiency. The HORSE W30 is a 3-liter engine that can be fitted in a transverse or longitudinal configuration, allowing it to be packaged in a wide variety of vehicles. The two rows of cylinders are offset at an angle of 90° to lower the engine’s center of gravity, improving ease of installation and optimizi
Montrose Environmental Group Is Now Onterris21.4.2026 22:05:00 CEST | Press release
Earth Day launch of new, unified brand highlights commitment “For Planet & Progress” Montrose Environmental Group (NYSE: MEG, changing to ONT May 4, 2026) will mark Earth Day by rebranding to Onterris. The new, unified brand reflects a purpose and broader role in tackling complex environmental challenges with scientific rigor, operational quality and precise execution. It also aligns expertise and market awareness to position the Company for its next phase of growth. Founded 14 years ago and operating across the U.S., Canada and Australia, the Company is a leading pure-play environmental solutions provider. While the name is new, the mission remains unchanged: advancing our way of life without compromising the integrity of our environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420842892/en/ At the heart of the new brand is a guiding principle: For Planet & Progress. “Onterris is more than a new name. This brand r
SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock21.4.2026 22:00:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the closing of its previously announced underwritten secondary public offering of 3,100,000 shares of the Company’s common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. The proceeds from the offering to the Selling Stockholder were approximately $10.1 million, before deducting underwriting discounts and commissions. The Company did not sell any shares of its common stock in the offering. The Selling Stockholder received all of the proceeds from the offering. Maxim Group LLC acted as the sole book-running manager and Roth Capital Partners acted as the co-manager for the offering. The offering was made pursuant to the Company’s effective shelf registration statement on Form S-3, including a base prospectus, filed with the U.S. Secur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom